Hence, our results suggested that DEPTOR may act as a tumor suppressor at the initiation stage of tumorigenesis, when cells express normal levels of DEPTOR; however, DEPTOR, whose expression is significantly enhanced by stresses or anticancer drug treatments, exhibits oncogenic properties to promote cancer cell survival and render the cells resistant to chemotherapeutic drugs30,31. The gene discussed is DEPTOR; the disease is cancer.